Your shopping cart is currently empty

Byakangelicin (Standard) is a reference standard for research and analysis in studies involving Byakangelicin. BYAKANGELICIN,a main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitor,and is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $1,060 | 7-10 days | 7-10 days |
| Description | Byakangelicin (Standard) is a reference standard for research and analysis in studies involving Byakangelicin. BYAKANGELICIN,a main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitor,and is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use. |
| Molecular Weight | 334.32 |
| Formula | C17H18O7 |
| Cas No. | 482-25-7 |
| Smiles | [H][C@@](O)(COc1c2occc2c(OC)c2ccc(=O)oc12)C(C)(C)O |
| Relative Density. | 1.373 g/cm3 |
| Storage | -20°C for 20 months |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.